文章摘要

文章信息/Info

Title:: Management of pulmonary arterial hypertension associated with congenital heart disease

作者:: 岳天霞综述; 袁杰审校; (哈尔滨医科大学附属第二医院心内科、心肌缺血省部共建教育部重点实验室，黑龙江哈尔滨 150086)

Author(s):: YUE Tianxia; YUAN Jie; (Department of Cardiology, Second Affiliated Hospital, Harbin Medical University, Harbin 150086, Heilongjiang, China)

关键词:: 先天性心脏病; 肺动脉高压; 生活质量; 管理

Keywords:: congenital heart disease; pulmonary arterial hypertension; quality of life; management

分类号:: R541.1

DOI:: -

文献标识码:: A

摘要:: 先天性心脏病相关肺动脉高压的发病机制复杂，本病对患者的生活质量有相当大的影响。虽然目前对这类疾病尚无有效的治疗措施，但通过合理的治疗干预可以延长患者的生存时间，改善其临床症状和生活质量。因此，有必要通过多学科小组的交流对这类患者进行适当的管理，以改善患者的生活质量和预后。

Abstract:: The mechanism of congenital heart diseases (CHD) associated with pulmonary arterial hypertension (PAH) is complicated and poor quality of life (QOL) is usually reported in patients with CHDPAH. Although there have been no effective therapies for CHDPAH, patients’ lifetime can be lengthened, QOL improved and clinical syndrome alleviated using reasonable treatment. Multidisciplinary treatment can improve QOL and prognosis in CHDPAH patients.

参考文献/References

[1]GinSing W.Pulmonary arterial hypertension:a multidisciplinary approach to care[J].Nursing Stand,2010,24(38):40-47.

[2]Marelli AJ,Therrien J,Mackie AS,et al.Planning the specialized care of adult congenital heart disease patients: from numbers to guidelines;an epidemiologic approach[J].Am Heart J,2009,157(1):1-8.

[3]Harrison JL,Silversides CK,Oechslin EN,et al. Health care needs of adults with congenital heart disease，Study of the patient perspective［J］. J Cardiovasc Nurs,2011,26(6):497-503.

[4]Hoendermis ES.Pulmonary arterial hypertension: an update[J].Neth Heart J,2011,19(12):514-522.

[5]Natarajan R.Recent trend in pulmonary arterial hypertention[J].Lung India,2011,28(1):39-48.

[6]Park MH.Advances in diagnosis and treatment in patients with pulmonary arterial hypertension[J].Catheter Cardiovasc Interv,2008,71(2):205-213.

[7]Teixeira FM,Coelho RM,Proena C,et al.Quality of Life experienced by adolescents and young adults with congenital heart disease[J].Pediatr Cardiol, 2011,32(8):1132-1138.

[8]McCollister DH,Beutz M,McLaughlin V,et al.Depressive symptoms in pulmonary arterial hypertension:prevalence and association with functional status[J].Psychosomatics, 2010,51(4):339-339.

[9]Silva AM,Vaz C,Areias ME,et al.Quality of life of patients with congenital heart diseases[J].Cardiol Young,2011,21(6):670-676.

[10]Galiè N,Hoeper MM,Humbert M,et al.Guidelines for the diagnosis and treatment of pulmonary hypertension:The task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation(ISHLT)[J].Eur Heart J,2009,30(2):2493-2537.

[11]吴险峰,程应樟.先天性心脏病并肺动脉高压研究新进展[J].岭南心血管病杂志,2009,15(6):485-488.

[12]丁仲如，秦永文.先天性心脏病合并肺动脉高压分级及性质的评估[J].介入放射学杂志,2008,17(7):523-526.

[13]钱红波,杨小龙.先天性心脏病合并肺动脉高压的诊疗进展[J].华北煤炭医学院学报,2011,13(2):176-178.

[14]Beghetti M,Tissot C.The right heart and pulmonary circulation(X):Pulmonary hypertension in congenital shunts[J].Rev Esp Cardiol,2010,63(10):1179-1193.

[15]Schuuring MJ,van Riel AC,Bouma BJ,et al.Recent progress in treatment of pulmonary arterial hypertension due to congenital heart disease[J].Neth Heart J,2011,19(12):495-497.

[16]Schuuring MJ,Boekholdt SM,Windhausen A,et al.Advanced therapy for pulmonary arterial hypertension due to congenital heart disease: a clinical perspective in a new therapeutic era[J].Neth Heart J,2011,19(12):509-513.

[17]Zeng WJ,Lu XL,Xiong CM,et al.The efficacy and safety of sildenafil in patients with pulmonary arterial hypertension associated with the different types of congenital heart disease[J].Clin Cardiol,2011,34(8):513-518.

[18]Madden BP.Pulmonary hypertension and pregnancy[J].Int J Obstet Anesth,2009,18(2):156-164.

[19]Badesch DB,Champion HC,Sanchez MA,et al.Diagnosis and assessment of pulmonary arterial hypertension[J].J Am Coll Cardiol,2009,54(1 Suppl):S55-S66.

[20]Diller GP,Gatzoulis MA.Pulmonary vascular disease in adults with congenital heart disease[J].Circulation,2007,115(8):1039-1050.

[21]Van De Bruaene A,Delcroix M,Pasquet A,et al.Iron deficiency is associated with adverse outcome in Eisenmenger patients[J].European Heart Journal,2011,32(22):2790-2799.

[22]邬晓臣,张近宝,欧阳辉,等.提高先天性心脏病并发肺动脉高压外科治疗效果的综合方案[J].心脏杂志,2012,24(3):381-384.

我们的网站为什么显示成这样？

先天性心脏病相关肺动脉高压患者的管理

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

文章信息/Info

参考文献/References

备注/Memo

常用功能

导航/Navigate

工具/Tools

统计/Statistics